Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Lung Cancer

  Free Subscription


Articles published in Ann Thorac Surg

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    June 2025
  1. XIE S, Hu Q, Wu Z, Wang B, et al
    Clinical and Genetic Characteristics of Early-Onset Lung Adenocarcinoma in a Large Chinese Cohort.
    Ann Thorac Surg. 2025;119:1196-1204.
    PubMed     Abstract available


    May 2025
  2. WU VS, Boutros C, Bassiri A, Jiang B, et al
    Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence.
    Ann Thorac Surg. 2025 May 28:S0003-4975(25)00448.
    PubMed     Abstract available


  3. LIANG H, Wang W, Zhang M, Wang R, et al
    Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
    Ann Thorac Surg. 2025 May 15:S0003-4975(25)00420.
    PubMed     Abstract available


  4. KALTMAN M, Yalamanchili S, Park JA, Weyant MJ, et al
    High catchment areas for lung cancer screening-eligible patients.
    Ann Thorac Surg. 2025 May 13:S0003-4975(25)00414.
    PubMed     Abstract available


  5. DING H, Tao B, Xu L, Jiang G, et al
    Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00378.
    PubMed     Abstract available


  6. KHAN AA, Shah SK, Naeem W, Ansari M, et al
    Association Between Social Vulnerability Index and Time-to-Treatment in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00380.
    PubMed     Abstract available


  7. LAM GT
    Medicaid Expansion and Regionalization of Lung Cancer Surgery: A Double-Edged Sword?
    Ann Thorac Surg. 2025 May 2:S0003-4975(25)00374.
    PubMed    


  8. WOODARD GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, et al
    Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation.
    Ann Thorac Surg. 2025;119:1071-1081.
    PubMed     Abstract available


    April 2025
  9. HOODA Z, Duan Z, Ries S, Antonoff MB, et al
    Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients.
    Ann Thorac Surg. 2025 Apr 11:S0003-4975(25)00321.
    PubMed     Abstract available


  10. CHEN J, Zhao ZR, Deng H, Yang C, et al
    Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer.
    Ann Thorac Surg. 2025 Apr 9:S0003-4975(25)00298.
    PubMed     Abstract available


  11. VANWINKLE CK, Fu W, Hassett KP, Thompson MP, et al
    The Association between Participation in a Quality Collaborative and Value in Lung Cancer Surgery.
    Ann Thorac Surg. 2025 Apr 5:S0003-4975(25)00295.
    PubMed     Abstract available


  12. RUSCH VW
    An unresolved surgical conundrum: How to manage unsuspected nodal involvement in early-stage lung cancer.
    Ann Thorac Surg. 2025 Apr 2:S0003-4975(25)00282.
    PubMed    


    March 2025
  13. SHAH SK, Khan AA, Basu S, Seder CW, et al
    Minimally Invasive Pneumonectomy vs Open Pneumonectomy: Outcomes and Predictors of Conversion.
    Ann Thorac Surg. 2025;119:634-642.
    PubMed     Abstract available


  14. EISENBERG M, Deboever N, Hofstetter WL, Mehran RJ, et al
    Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
    Ann Thorac Surg. 2025;119:616-624.
    PubMed     Abstract available


    February 2025
  15. VERGE R, Rouch A, Rabinel P, Renaud C, et al
    Evaluation of uncertain resection for localized non-small cell lung cancer: the crucial prognosis of suboptimal lymph node assessment.
    Ann Thorac Surg. 2025 Feb 27:S0003-4975(25)00170.
    PubMed     Abstract available


  16. FARINA JM, D'Cunha J
    Sorting Out the Pieces of Fragmented Lung Cancer Care.
    Ann Thorac Surg. 2025 Feb 19:S0003-4975(25)00120.
    PubMed    


  17. CROSINA J, Wright F, Irish J, Rashid M, et al
    Long-Term Impact of Regionalization of Thoracic Oncology Surgery.
    Ann Thorac Surg. 2025;119:460-469.
    PubMed     Abstract available


  18. RESIO BJ, Tan KS, Skovgard M, Dycoco J, et al
    Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection.
    Ann Thorac Surg. 2025;119:308-315.
    PubMed     Abstract available


  19. HUANG L, Petersen RH
    Impact of Margin Distance on Locoregional Recurrence and Survival After Thoracoscopic Segmentectomy.
    Ann Thorac Surg. 2025;119:316-324.
    PubMed     Abstract available


  20. HAYANGA JWA, Luo X, Hasasna I, Rothenberg P, et al
    Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung Surgery.
    Ann Thorac Surg. 2025;119:325-332.
    PubMed     Abstract available


    January 2025
  21. POTTER AL, Guo Q, Srinivasan D, Yang ME, et al
    Assessing Lung Cancer Screening Eligibility of Lung Cancer Patients in the Boston Lung Cancer Study: An Analysis of 7,186 Lung Cancer Cases.
    Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00067.
    PubMed     Abstract available


  22. ANTONOFF MB, Mitchell KG, Kim SS, Salfity HV, et al
    The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jan 9:S0003-4975(24)00960.
    PubMed     Abstract available


  23. KRANTZ SB, Mitzman B, Antonoff MB, Backhus L, et al
    Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High Quality Wedge Resection for Early Stage Lung Cancer.
    Ann Thorac Surg. 2025 Jan 8:S0003-4975(25)00004.
    PubMed     Abstract available


  24. MIMAE T, Miyata Y, Tsubokawa N, Kudo Y, et al
    Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.
    Ann Thorac Surg. 2025;119:192-198.
    PubMed     Abstract available


    December 2024
  25. STUART CM, Mott NM, Bronsert MR, Randhawa SK, et al
    The Association between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Dec 24:S0003-4975(24)01115.
    PubMed     Abstract available


  26. MATSUDO K, Takada K, Kinoshita F, Hashinokuchi A, et al
    CD155 Expression in Early-Stage Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:1197-1205.
    PubMed     Abstract available


    November 2024
  27. HOODA Z, Antonoff MB
    Using Lung Cancer Screening To Treat the Whole Patient, Not the Disease.
    Ann Thorac Surg. 2024 Nov 27:S0003-4975(24)01017.
    PubMed    


  28. AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al
    Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer
    Ann Thorac Surg. 2024 Nov 13:S0003-4975(24)00957.
    PubMed     Abstract available


  29. ODEH A, Verm R, Park S, Swanson J, et al
    Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer.
    Ann Thorac Surg. 2024 Nov 11:S0003-4975(24)00940.
    PubMed     Abstract available


  30. LANUTI M
    What Is Best Liquid Remnant for Resected Early-Stage Non-small Cell Lung Cancer?
    Ann Thorac Surg. 2024;118:1144-1145.
    PubMed    


    October 2024
  31. ELY S, Osarogiagbon RU
    Metrics for Benchmarking Lung Cancer Surgery Quality: Not waiting for Godot!
    Ann Thorac Surg. 2024 Oct 29:S0003-4975(24)00924.
    PubMed    


  32. HOODA Z, Antonoff MB
    Less is More-Further Evidence Favoring Segmentectomy for Clinical Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00882.
    PubMed    


  33. LI Z, Wu L, Wang C, Wang S, et al
    Outcomes after neoadjuvant therapy with/without immunotherapy followed by pneumonectomy in non-small cell lung cancer patients.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00879.
    PubMed     Abstract available


  34. D'ANDRILLI A, Marinucci BT, Ciccone AM, Ibrahim M, et al
    CARINAL RECONSTRUCTION FOR LUNG CANCER AND AIRWAY TUMORS: LONG-TERM RESULTS.
    Ann Thorac Surg. 2024 Oct 22:S0003-4975(24)00876.
    PubMed     Abstract available


  35. LI X, Li Q, Yang F, Gao E, et al
    Survival Outcomes of Neoadjuvant Therapy Followed by Sleeve Lobectomy in Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 17:S0003-4975(24)00863.
    PubMed     Abstract available


  36. KIM SS, Cooke DT, Kidane B, Tapias LF, et al
    The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00861.
    PubMed     Abstract available


  37. RUSCH VW
    Sublobar Resection for Subsolid Lung Adenocarcinomas: How Much Margin Is Enough?
    Ann Thorac Surg. 2024;118:810.
    PubMed    


  38. GROTH SS
    Unraveling the Association Between Size of Lepidic-Predominant Adenocarcinomas and the Risk of Nodal Metastasis.
    Ann Thorac Surg. 2024;118:823-824.
    PubMed    


  39. KAMTAM DN, Berry MF, Lui NS, Satoyoshi M, et al
    What Is an Adequate Margin During Sublobar Resection of
    Ann Thorac Surg. 2024;118:801-809.
    PubMed     Abstract available


  40. SI H, Xu L, Zhao Y, Su H, et al
    Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:825-833.
    PubMed     Abstract available


  41. WONG LY, Elliott IA, Liou DZ, Backhus LM, et al
    Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Before Treating?
    Ann Thorac Surg. 2024;118:817-823.
    PubMed     Abstract available


    September 2024
  42. XU R, Miao P
    Public health and social work collaborative rehabilitation assessment of different lung cancer resection.
    Ann Thorac Surg. 2024 Sep 20:S0003-4975(24)00825.
    PubMed    


  43. BROWNLEE AR
    When a Lung Nodule Program Becomes Self-Aware.
    Ann Thorac Surg. 2024;118:718-719.
    PubMed    


  44. KRANTZ SB, Su KW
    More for More's Sake Alone? Completion Lobectomy in the Setting of Occult Nodal Disease.
    Ann Thorac Surg. 2024;118:663-664.
    PubMed    


  45. HEADRICK JR JR, Parker MJ, Miller AD
    Artificial Intelligence: Can It Save Lives, Hospitals, and Lung Screening?
    Ann Thorac Surg. 2024;118:712-718.
    PubMed     Abstract available


  46. KNEUERTZ PJ
    Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC.
    Ann Thorac Surg. 2024;118:681-682.
    PubMed    


  47. MARTIN JL, Mack SJ, Rshaidat H, Collins ML, et al
    Wedge Resection Outcomes: A Comparison of Video-Assisted and Robot-Assisted Wedge Resections.
    Ann Thorac Surg. 2024;118:683-690.
    PubMed     Abstract available


    August 2024
  48. BROWN LM, Bonnell L, Parsons N, Cooke DT, et al
    Predictors of Discharge with Supplemental Oxygen after Lobectomy for Lung Cancer.
    Ann Thorac Surg. 2024 Aug 28:S0003-4975(24)00693.
    PubMed     Abstract available


  49. MCALLISTER MA, Herrera-Zamora J, Barcelos RR, Leo R, et al
    Left Upper Lobectomy versus Trisegmentectomy for Lung Cancer: A Propensity-Score Matched Comparison.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00684.
    PubMed     Abstract available


  50. TONG BC, Bonnell LN, Habib RH, Shahian DM, et al
    The STS 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00686.
    PubMed     Abstract available


  51. ROSSETTI NE, Eaton DB Jr, Tohmasi S, Heiden BT, et al
    Early-stage lung cancer in the era of lung cancer screening: VA outperforms other insurance models.
    Ann Thorac Surg. 2024 Aug 21:S0003-4975(24)00678.
    PubMed     Abstract available


  52. MITZMAN B
    The Entire NSCLC Spectrum: No Cancer Left Behind.
    Ann Thorac Surg. 2024;118:393-394.
    PubMed    


  53. DAI J, Sun F, Bao M, Cao J, et al
    Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
    Ann Thorac Surg. 2024;118:365-374.
    PubMed     Abstract available


  54. CAMPISI A, Dell'Amore A, Faccioli E, Fang W, et al
    A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies.
    Ann Thorac Surg. 2024;118:375-383.
    PubMed     Abstract available


  55. WAN S, Shen Z, Hu S, Zhang L, et al
    Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma.
    Ann Thorac Surg. 2024;118:385-393.
    PubMed     Abstract available


    July 2024
  56. RUSCH VW
    Surgical Resection for Pleural Mesothelioma: Is It All About Patient Selection?
    Ann Thorac Surg. 2024;118:223-224.
    PubMed    


  57. NAKAMURA A, Hashimoto M, Kuroda A, Matsumoto S, et al
    Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma.
    Ann Thorac Surg. 2024;118:216-223.
    PubMed     Abstract available


  58. KAGIMOTO A, Ishida M, Mimura T
    Significance of the Goddard Score in Predicting Complications Related to Air Leak After Lobectomy.
    Ann Thorac Surg. 2024;118:233-239.
    PubMed     Abstract available


    June 2024
  59. WONG LY, Dale R, Kapula N, Elliott IA, et al
    Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
    Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00460.
    PubMed     Abstract available


  60. NOBEL TB, Tan KS, Adusumilli PS, Bains MS, et al
    Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00448.
    PubMed     Abstract available


  61. BRIBRIESCO A
    Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1119-1120.
    PubMed    


  62. YANG F, Sun K, Li F, Li X, et al
    The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1111-1119.
    PubMed     Abstract available


    May 2024
  63. BOU-SAMRA P, Kennedy GT, Chang A, Guo E, et al
    Phase 2 Trial of VGT-309: Cathepsin-Based Near-Infrared Probe for Intraoperative Molecular Imaging.
    Ann Thorac Surg. 2024 May 30:S0003-4975(24)00396.
    PubMed     Abstract available


  64. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
    Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
    Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
    PubMed     Abstract available


  65. RUSCH VW
    Wedge Resection Versus Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?
    Ann Thorac Surg. 2024 May 9:S0003-4975(24)00359.
    PubMed    


    April 2024
  66. TAKAHASHI T
    Study-design of adjuvant chemotherapy for lung cancer: A cart before the horse.
    Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00285.
    PubMed    


  67. SHAHZAD MH, Spicer JD, Rusch VW, Kneuertz PJ, et al
    Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer - Current Evidence and Future Directions.
    Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00280.
    PubMed     Abstract available


  68. BLASBERG JD, Li A
    Evening the Odds: Making 1 + 1 = 2 for Bilobectomy.
    Ann Thorac Surg. 2024;117:874-875.
    PubMed    


  69. KAMIGAICHI A, Mimae T, Tsubokawa N, Miyata Y, et al
    Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:743-751.
    PubMed     Abstract available


    March 2024
  70. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
    STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
    PubMed     Abstract available


  71. FERRARIS VA
    Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
    PubMed    


  72. STILES BM, Rodriguez-Quintero JH
    A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
    Ann Thorac Surg. 2024;117:593.
    PubMed    


    February 2024
  73. ALDERETE IS, Nakata K, Hartwig MG
    Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
    PubMed    


  74. PONTULA A, Spies CS, Hartwig MG
    Incidentally Found Lung Cancer Following Lung Transplantation: Apples and Oranges.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
    PubMed    


  75. DUNNE EG, Fick CN, Isbell JM, Chaft JE, et al
    The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
    PubMed     Abstract available


  76. YOUNG AM, Viktorsson SA, Strobel RJ, Rotar EP, et al
    Five-Year Sustained Impact of a Thoracic Enhanced Recovery After Surgery Program.
    Ann Thorac Surg. 2024;117:422-430.
    PubMed     Abstract available


  77. FERRARI-LIGHT D, Kneuertz PJ
    Life in the Fast Lane: Rapid Discharge After Minimally Invasive Anatomic Lung Resection Is Feasible and Safe.
    Ann Thorac Surg. 2024;117:303-304.
    PubMed    


    January 2024
  78. COSTER JN, Sanchez PG
    Surviving Incidentally Found Non-Small Cell Lung Cancer After Lung Transplantation.
    Ann Thorac Surg. 2024 Jan 27:S0003-4975(24)00071.
    PubMed    


  79. FONG AJ, Reich H, Mirocha J, Wong A, et al
    Disparities and Underutilization of Surgery for Early Stage Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Jan 26:S0003-4975(24)00067.
    PubMed     Abstract available


  80. AXTELL AL, Gaissert HA, Bao X, Auchincloss HG, et al
    Predictors of Venous Thromboembolism after Lung Cancer Resection.
    Ann Thorac Surg. 2024 Jan 25:S0003-4975(24)00014.
    PubMed     Abstract available


  81. MARTINS RS, Razi SS, Alnajar A, Poulikidis K, et al
    Neoadjuvant versus Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Jan 19:S0003-4975(24)00013.
    PubMed     Abstract available


  82. POTTER AL, Senthil P, Keshwani A, McCleery S, et al
    Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
    Ann Thorac Surg. 2024 Jan 10:S0003-4975(24)00004.
    PubMed     Abstract available


  83. MIMAE T, Miyata Y, Tsubokawa N, Shimada Y, et al
    Sublobar resection in early non-small cell lung cancer with epidermal growth factor receptor mutant.
    Ann Thorac Surg. 2024 Jan 8:S0003-4975(24)00002.
    PubMed     Abstract available


  84. KNEUERTZ PJ, Ferrari-Light D, Altorki NK
    Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials.
    Ann Thorac Surg. 2024 Jan 5:S0003-4975(24)00001.
    PubMed     Abstract available


  85. LI AX, Canavan ME, Ermer T, Maduka RC, et al
    Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy.
    Ann Thorac Surg. 2024;117:163-171.
    PubMed     Abstract available


    November 2023
  86. COLLINS ML, Mack SJ, Whitehorn GL, Till BM, et al
    Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
    Ann Thorac Surg. 2023 Nov 21:S0003-4975(23)01165.
    PubMed     Abstract available


  87. YUN T, Zhang Y, Liu A, Qin Y, et al
    Randomized Trial of Modified Chest Tube Placement vs Routine Placement After Lung Resection.
    Ann Thorac Surg. 2023;116:1013-1019.
    PubMed     Abstract available


    October 2023
  88. MORKVED AL, Sogaard M, Skjoth F, Ording AG, et al
    Risk and timing of venous thromboembolism after surgery for lung cancer: a nationwide cohort study.
    Ann Thorac Surg. 2023 Oct 25:S0003-4975(23)01073.
    PubMed     Abstract available


  89. RSHAIDAT H, Okusanya OT
    Using the Ultimate Lung Biopsy.
    Ann Thorac Surg. 2023;116:701-702.
    PubMed    


    September 2023
  90. RUSCH VW
    Process improvement in lymphadenectomy for lung cancer: The wave of the future?
    Ann Thorac Surg. 2023 Sep 15:S0003-4975(23)00958.
    PubMed    


  91. SPIES CS, Ochoa TN, Pontula A, Harris CS, et al
    With Comparable Outcomes, Should Early Stage Lung Cancer Be A Contraindication to Lung Transplant?
    Ann Thorac Surg. 2023 Sep 11:S0003-4975(23)00934.
    PubMed     Abstract available


  92. OSAROGIAGBON RU, Ray MA, Fehnel C, Akinbobola O, et al
    Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
    Ann Thorac Surg. 2023 Sep 5:S0003-4975(23)00927.
    PubMed     Abstract available


    August 2023
  93. POTTER AL, Spasojevic A, Raman V, Hurd JC, et al
    The Increasing Adoption of Minimally Invasive Lobectomy in the United States.
    Ann Thorac Surg. 2023;116:222-229.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.